[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,922
  • Shares Outstanding, K 1,985
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,770 K
  • EBIT $ -9 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.23
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.56

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.71 +133.33%
on 04/17/26
7.88 -49.37%
on 04/24/26
+1.85 (+86.45%)
since 04/01/26
3-Month
1.71 +133.33%
on 04/17/26
7.88 -49.37%
on 04/24/26
+1.08 (+37.11%)
since 01/30/26
52-Week
1.71 +133.33%
on 04/17/26
17.84 -77.64%
on 05/13/25
-11.37 (-74.02%)
since 05/01/25

Most Recent Stories

More News
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

Appointment strengthens Board with seasoned public company biotech executive following recent Nasdaq direct listing

LABT : 3.43 (+28.95%)
ENVB : 3.99 (+1.01%)
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological...

ENVB : 3.99 (+1.01%)
Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$5 million upfront with up to approximately $8.9 million of potential aggregate proceeds upon the exercise in full of warrants

ENVB : 3.99 (+1.01%)
Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$5 million upfront with up to approximately $8.9 million of potential aggregate proceeds upon the exercise in full of warrants

ENVB : 3.99 (+1.01%)
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates

Patent provides added depth to Enveric’s EVM301 intellectual property portfolio of potential neuroplastogenic molecules for non-hallucinogenic treatment of neuropsychiatric conditions

ENVB : 3.99 (+1.01%)
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025

Product Development Highlights: Reported positive preclinical results for lead drug candidate EB-003, showing statistically significant improvements...

ENVB : 3.99 (+1.01%)
Enveric Biosciences Announces Registration of Five Trademarks

Canadian Trademark Office Issues House Marks to Enveric Biosciences, Inc.

ENVB : 3.99 (+1.01%)
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent

As a result of this action, there are no remaining challenges currently pending against Enveric’s patent

ENVB : 3.99 (+1.01%)
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data

Proprietary assays demonstrate dual Gq and β-arrestin signaling at 5-HT₂ A , pathways linked in peer-reviewed studies to antidepressant and anxiolytic effects ...

ENVB : 3.99 (+1.01%)
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option

RCANN ™ Trademark Portfolio Out-Licensed

ENVB : 3.99 (+1.01%)

Business Summary

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

See More

Key Turning Points

3rd Resistance Point 5.39
2nd Resistance Point 4.99
1st Resistance Point 4.49
Last Price 3.99
1st Support Level 3.60
2nd Support Level 3.20
3rd Support Level 2.70

See More

52-Week High 17.84
Fibonacci 61.8% 11.68
Fibonacci 50% 9.78
Fibonacci 38.2% 7.87
Last Price 3.99
52-Week Low 1.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.